Search
for
Sort by
Research 241–270 of 1000+
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- New drugs under investigation for the treatment of alopecias
- Pathomechanisms of immune-mediated alopecia
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Novedades terapéuticas en tricología
- Alopecia in general medicine
- Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment
- What’s New in Hair Loss
- Alopecia areata: medical treatments
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Alopecia Areata: The Clinical Situation
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Successful treatment of alopecia totalis with tofacitinib in a Danish patient
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Alopecia areata
- TREMendous Macrophages Inhibit Hair Growth
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review